johnson & johnson news - Search News

Intra, Cellular and Johnson & Johnson

Reuters on MSN · 5h

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports

(Reuters) -Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, Bloomberg News reported on Sunday, citing people familiar with the matter.

Hosted on MSN · 5h

Johnson & Johnson Is Exploring Bid for Intra-Cellular Therapies

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.

Business Insider · 1h

Johnson & Johnson In Talks To Acquire Intra-Cellular Therapies : Report

Johnson & Johnson (JNJ) is in talks to acquire Intra-Cellular Therapies Inc. (ITCI), a biopharmaceutical company focused on

Seeking Alpha on MSN · 5h

Johnson & Johnson exploring takeover of Intra-Cellular - Bloomberg

Johnson & Johnson (JNJ) is evaluating an offer to purchase Intra-Cellular Therapies (NASDAQ:ITCI). Deliberations are on going, and it's not a certainty that JNJ will make an offer for the biotech firm focused on treatments for mental health disorders,

Patriots, Ben Johnson and Oakland Raiders

Raiders Wire · 10h

Patriots find their new head coach, removing themselves from Raiders competitors

With Mike Vrabel going to the Patirots, there are now just five teams with head coach openings — Raiders, Jets, Bears, Jaguars, and Saints.

USA TODAY Touchdown Wire o… · 1d

Could Ben Johnson really become the next head coach for the Raiders?

It's been a few years in the making for Detroit Lions offensive coordinator Ben Johnson to become a head coach for an NFL team. The only hold up has been about Johnson finding the right fit or not. However,

Boston.com on MSN · 1d

5 things to know about Patriots head coach candidate Ben Johnson

Johnson has a local tie and a link with the team's most important player. The post 5 things to know about Patriots head coach candidate Ben Johnson appeared first on Boston.com.

1d

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

2d

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

2don MSN

Johnson & Johnson stock outperforms competitors despite losses on the day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

3d

Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

4d

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results